Table 3.

Timing of Earliest Administration of Immunizations after Chemotherapy or HSCT by Program.

	3 months	6 months	9 months	12 months	24 months	Not specified
	n (%)	n (%)	n (%)	n (%)	n (%)	n (%)
ALL (N = 11)
Inactivated vaccines*	4 (36)	6 (55)	—	—	—	1 (9)
Live attenuated vaccines	3 (27)	3 (27)	—	4 (36)	—	1 (9)
Post-HSCT (N = 9)
Pneumococcal conjugate vaccine	4 (44)	1 (11)	—	4 (44)	—	—
Other inactivated vaccines†	—	3 (33)	1 (11)	5 (56)	—	—
Live attenuated vaccines‡	—	—	—	1 (11)	8 (89)

ALL, acute lymphocytic leukemia; HSCT, hematopoietic stem cell transplant

^*Excludes inactivated influenza vaccines.

^†Excluding PCV13 and inactivated influenza vaccines, but including tetanus-diphtheria-acellular pertussis, Haemophilus influenzae type b, inactivated polio, hepatitis AB, hepatitis B, human papillomavirus, quadrivalent meningococcal conjugate, meningococcal serogroup C conjugate vaccines.

^‡Measles, mumps, rubella, varicella.